✦ LIBER ✦

Managing progressive disease in patients with GIST: Factors to consider besides acquired secondary tyrosine kinase inhibitor resistance

✍ Scribed by Shreyaskumar Patel

Book ID: 116395615
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 467 KB
Volume: 38
Category: Article
ISSN: 0305-7372
DOI: 10.1016/j.ctrv.2011.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Significance of Heterogeneity i

Clinical Significance of Heterogeneity in Response to Retreatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Cancer Acquiring Secondary Resistance to the Drug

✍ Lee, Youngjoo; Kim, Hyae Young; Lee, Soo-Hyun; Lim, Kun Young; Lee, Geon Kook; Y 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 764 KB

Management of acquired resistance to epi

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non-small cell lung cancer

✍ Sacher, Adrian G.; Jänne, Pasi A.; Oxnard, Geoffrey R. 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB

Disease Flare after Tyrosine Kinase Inhi

Disease Flare after Tyrosine Kinase Inhibitor Discontinuation in Patients with EGFR-Mutant Lung Cancer and Acquired Resistance to Erlotinib or Gefitinib: Implications for Clinical Trial Design

✍ Chaft, J. E.; Oxnard, G. R.; Sima, C. S.; Kris, M. G.; Miller, V. A.; Riely, G. 📂 Article 📅 2011 🏛 American Association for Cancer Research 🌐 English ⚖ 338 KB

EKB-569, a new irreversible epidermal gr

EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib

✍ Yoshimura, Naruo; Kudoh, Shinzoh; Kimura, Tatsuo; Mitsuoka, Shigeki; Matsuura, K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 149 KB

The BCR–ABL1 T315I mutation and addition

The BCR–ABL1 T315I mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy

✍ Malcikova, Jitka; Razga, Filip; Jurcek, Tomas; Dvorakova, Dana; Zackova, Daniela 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 244 KB